<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) are at increased risk of colorectal <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> is the commonest type of colorectal <z:hpo ids='HP_0002664'>neoplasm</z:hpo> associated with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, but other types of epithelial and non-<z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumors</z:e> have also been described in inflamed bowel </plain></SENT>
<SENT sid="2" pm="."><plain>With regards to non-epithelial <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0100242'>sarcomas</z:hpo> represent the largest group of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> reported in association with IBD, especially in immunosuppressed patients </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0100570'>Carcinoids</z:hpo> and in particular <z:hpo ids='HP_0100634'>neuroendocrine neoplasms</z:hpo> other than <z:hpo ids='HP_0100570'>carcinoids</z:hpo> (NENs) are rare <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and are infrequently described in the setting of IBD </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, this association requires further investigation </plain></SENT>
<SENT sid="5" pm="."><plain>We report two cases of <z:hpo ids='HP_0002664'>neoplasms</z:hpo> arising in mild left-sided UC with immunohistochemical staining for neuroendocrine markers: a large cell and a small cell neuroendocrine <z:mp ids='MP_0002038'>carcinoma</z:mp> of the rectum </plain></SENT>
<SENT sid="6" pm="."><plain>The two patients were different in age (35 years vs 77 years) and disease duration (11 years vs 27 years), and both had never received <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi> drugs </plain></SENT>
<SENT sid="7" pm="."><plain>Although the patients underwent regular endoscopic and histological follow-up, the two <z:hpo ids='HP_0002664'>neoplasms</z:hpo> were locally advanced at diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>One of the two patients developed multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and died 15 mo after diagnosis </plain></SENT>
<SENT sid="9" pm="."><plain>These findings confirm the <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> and the poor prognosis of NENs compared to colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>While <z:hpo ids='HP_0100570'>carcinoids</z:hpo> seem to be coincidentally associated with IBD, NENs may also arise in this setting </plain></SENT>
<SENT sid="11" pm="."><plain>In fact, long-standing <z:mp ids='MP_0001845'>inflammation</z:mp> could be directly responsible for the development of pancellular <z:mpath ids='MPATH_589'>dysplasia</z:mpath> involving epithelial, goblet, Paneth and neuroendocrine cells </plain></SENT>
<SENT sid="12" pm="."><plain>It has yet to be established which IBD patients have a higher risk of developing NENs </plain></SENT>
</text></document>